초록 ▼

Methods of detecting at least one genetic variation in a polynucleotide analyte in a sample. A fluorophore is attached to a first primer, a quencher is attached to a second primer, the first primer and the second primer are specific for the polynucleotide analyte. A signal generated by the fluoropho

Methods of detecting at least one genetic variation in a polynucleotide analyte in a sample. A fluorophore is attached to a first primer, a quencher is attached to a second primer, the first primer and the second primer are specific for the polynucleotide analyte. A signal generated by the fluorophore and quencher is measured. PCR is performed with the first primer and the second primer using the polynucleotide analyte as a template, thereby amplifying the template. A signal generated by the fluorophore and quencher from the PCR amplification product is measured. Comparison is made of the signals; and a determination is made of the presence or absence of the at least one genetic variation based i) on the change in signal as determined; and ii) by comparing said change to the change in signal observed upon PCR amplification for a corresponding polynucleotide analyte lacking the at least one genetic variation.

대표청구항 ▼

1. A method of detecting at least one genetic variation in a polynucleotide analyte in a sample, comprising: a) combining the sample comprising the polynucleotide analyte with a first primer and a second primer, wherein a fluorophore is attached to the first primer, a quencher is attached to the sec

1. A method of detecting at least one genetic variation in a polynucleotide analyte in a sample, comprising: a) combining the sample comprising the polynucleotide analyte with a first primer and a second primer, wherein a fluorophore is attached to the first primer, a quencher is attached to the second primer, the first primer and the second primer are specific for the first polynucleotide analyte, at least one of the first primer and the second primer hybridizes to a region of the polynucleotide analyte encoding the at least one genetic variation, and the fluorophore is different from the quencher;b) measuring a first signal generated by the fluorophore and quencher;c) performing at least one polymerase chain reaction (PCR) reaction with the first primer and the second primer using the polynucleotide analyte as a template, thereby amplifying the template to generate a PCR amplification product comprising the at least one genetic variation;d) measuring a second signal generated by the fluorophore and quencher from the PCR amplification product;e) comparing the first and second signals to determine a change between the first and second signals; andf) determining the presence or absence of the at least one genetic variation based i) on the change in signal as determined in step e); and ii) by comparing said change to the change in signal observed upon PCR amplification for a corresponding polynucleotide analyte lacking the at least one genetic variation in the presence of the first primer and the second primer. 2. The method of claim 1, wherein the at least one genetic variation is present when the change in signal as determined in step e) is a decrease in change when compared to the change in signal observed for the corresponding polynucleotide analyte lacking the at least one genetic variation. 3. The method of claim 1, wherein the genetic variation comprises a single-nucleotide polymorphism (SNP). 4. The method of claim 3, wherein the first primer hybridizes to a region of the polynucleotide analyte encoding the SNP. 5. The method of claim 3, wherein the second primer hybridizes to a region of the polynucleotide analyte encoding the SNP. 6. The method of claim 1, wherein the change in signal as determined in step e) is distinct for UU, UT, UG, UC, UA, AA, TT, GG, CC, AG, AC, TG, and TC. 7. The method of claim 1, wherein the fluorophore is attached to the 5′ end of the first primer. 8. The method of claim 1, wherein the fluorophore is 6-FAM (Fluorescein), 6-FAM (NHS Ester), Fluorescein dT, HEX, JOE (NHS Ester), MAX, TET, ROX, TAMRA, TARMA (NHS Ester), TEX 615, ATTO 488, ATTO 532, ATTO 550, ATTO 565, ATTO Rho101, ATTO 590, ATTO 633, ATTO 647N, TYE 563, TYE 665 or TYE 705. 9. The method of claim 1, wherein the quencher is attached to the 5′ end of the second primer. 10. The method of claim 1, wherein the quencher is Iowa Black FG, Iowa Black RG, BHQ1, BHQ2 or BHQ3. 11. The method of claim 1, wherein the decrease in fluorescent intensity is at least, or about, a 30% decrease in signal. 12. The method of claim 1, wherein the PCR reaction is an end-point polymerase chain reaction process, a real-time polymerase chain reaction process, a digital polymerase chain reaction process, a droplet digital polymerase chain reaction process, or a quantitative polymerase chain reaction process. 13. The method of claim 1, wherein the PCR reaction is a quantitative PCR process. 14. The method of claim 1, wherein the concentration of the polynucleotide analyte is from about 10 μM to about 10 aM. 15. The method of claim 1, wherein the polynucleotide analyte is a DNA polynucleotide analyte or an RNA polynucleotide analyte. 16. The method of claim 1, further comprising detecting at least one additional polynucleotide analyte within the sample with an additional fluorophore attached to a primer, wherein the fluorophore is the same color as the additional fluorophore. 17. The method of claim 1, wherein the polynucleotide analyte is from about 10 to about 500 nucleotides in length. 18. The method of claim 1, wherein the first primer encodes a region on the analyte less than 500 base pairs away from a region encoded by the second primer. 19. The method of claim 3, wherein the SNP is associated with a disease, optionally a genetic disorder, an autoimmune disease, a neurological disease, a cardiovascular disease, or a cancer. 20. The method of claim 1, wherein when the first primer is hybridized to the region of the polynucleotide analyte encoding the at least one genetic variation, the fluorophore is attached to a portion of the first primer that is 5′ to the site of the at least one genetic variation. 21. The method of claim 1, wherein when the second primer is hybridized to the region of the polynucleotide analyte encoding the at least one genetic variation, the quencher is attached to a portion of the second primer that is 5′ to the site of the at least one genetic variation. 22. The method of claim 1, wherein the genetic variation comprises a deletion, an insertion, a point mutation, a base-pair substitution, or a variation in the number of multiple nucleotide repetition. 23. The method of claim 1, wherein the corresponding polynucleotide analyte is a wild-type analyte.